Farmaci oncologici

Queste aziende sviluppano o vendono farmaci contro il cancro, come pillole, anticorpi, terapie cellulari e vaccini.
+44,3%
in 1 anno · S&P 500 +11,6%

Indicatori chiave

Salute
49 / 100
Fragile
Solido
Prezzo
P/E 40
Economico
Caro
In rialzo su 1 anno
57 su 105
Wallet su 90 giorni
2 / 5 acquisti / vendite
Acquisti
Vendite
Salute e prezzo: rispetto agli altri tag.
Con TrueWallet Pro
Tutti gli indicatori di Farmaci oncologici fanno parte di TrueWallet Pro.
Accedi

Le 113 aziende

LLY
+42,7%
JNJ
+50,3%
ABBV
+29,5%
MRK
Dimensione: peso nel tag. Colore: variazione nel periodo.
Vedi tutte le aziende
L
Eli Lilly
LLY
33,3%
+42,7%
J
Johnson & Johnson
JNJ
16,5%
+50,3%
A
AbbVie
ABBV
12,9%
+29,5%
M
Merck
MRK
9,0%
+66,3%
A
Amgen
AMGN
6,2%
+42,3%
G
Gilead Sciences
GILD
5,2%
+39,6%
P
Pfizer
PFE
4,1%
+19,1%
B
Bristol-Myers Squibb
BMY
3,1%
+35,0%
R
Regeneron Pharmaceuticals
REGN
2,3%
+40,9%
M
Moderna
MRNA
2,2%
+736,3%
R
Revolution Medicines
RVMD
1,1%
+161,7%
I
Incyte
INCY
0,6%
+11,7%
E
Exelixis
EXEL
0,4%
+58,3%
S
Summit Therapeutics
SMMT
0,3%
−24,9%
C
Corcept Therapeutics
CORT
0,2%
−7,0%
I
ImmunityBio
IBRX
0,2%
+192,2%
C
CG Oncology
CGON
0,2%
+88,8%
E
Erasca
ERAS
0,1%
+490,9%
C
Cogent Biosciences
COGT
0,1%
−19,0%
L
Legend Biotech
LEGN
<0,1%
−43,9%
R
Relay Therapeutics
RLAY
<0,1%
+193,2%
T
Tango Therapeutics
TNGX
<0,1%
+232,5%
E
Enliven Therapeutics
ELVN
<0,1%
+140,4%
I
Iovance Biotherapeutics
IOVA
<0,1%
+205,5%
P
Parabilis Medicines
PBLS
<0,1%
C
Celcuity
CELC
<0,1%
−24,4%
I
IDEAYA Biosciences
IDYA
<0,1%
−0,4%
X
Xencor
XNCR
<0,1%
+157,7%
R
Arcus Biosciences
RCUS
<0,1%
−12,9%
B
Biohaven
BHVN
<0,1%
+73,8%
I
Immunome
IMNM
<0,1%
+7,7%
R
Recursion Pharmaceuticals
RXRX
<0,1%
−31,5%
R
Replimune Group
REPL
<0,1%
+142,1%
V
Vir Biotechnology
VIR
<0,1%
+74,4%
Z
Zymeworks
ZYME
<0,1%
+35,5%
S
SELLAS Life Sciences
SLS
<0,1%
+427,5%
P
Precigen
PGEN
<0,1%
+12,9%
N
Nurix Therapeutics
NRIX
<0,1%
+27,2%
N
Nuvation Bio
NUVB
<0,1%
−19,1%
T
Tyra Biosciences
TYRA
<0,1%
+29,4%
D
Damora Therapeutics
DMRA
<0,1%
−8,5%
I
Inhibrx
INBX
<0,1%
+13,6%
V
Verastem
VSTM
<0,1%
−3,9%
C
Corvus Pharmaceuticals
CRVS
<0,1%
+30,1%
A
Aktis Oncology
AKTS
<0,1%
O
Oric Pharmaceuticals
ORIC
<0,1%
−37,0%
S
Syndax Pharmaceuticals
SNDX
<0,1%
−43,7%
R
Rigel Pharmaceuticals
RIGL
<0,1%
+11,3%
O
Obsidian Therapeutics
OBX
<0,1%
A
Aura Biosciences
AURA
<0,1%
+27,6%
S
Sana Biotechnology
SANA
<0,1%
−50,2%
C
Cullinan Therapeutics
CGEM
<0,1%
+23,1%
F
Fulgent Genetics
FLGT
<0,1%
−15,2%
N
Nuvectis Pharma
NVCT
<0,1%
+236,8%
D
Delcath Systems
DCTH
<0,1%
+139,2%
K
Kura Oncology
KURA
<0,1%
−27,2%
C
Candel Therapeutics
CADL
<0,1%
+26,0%
O
Olema Pharmaceuticals
OLMA
<0,1%
−6,2%
J
Janux Therapeutics
JANX
<0,1%
−60,1%
B
Bicara Therapeutics
BCAX
<0,1%
−32,8%
A
ArriVent BioPharma
AVBP
<0,1%
−35,6%
G
Geron
GERN
<0,1%
−22,0%
C
Crescent Biopharma
CBIO
<0,1%
+8,4%
M
Monopar Therapeutics
MNPR
<0,1%
−12,8%
C
CytomX Therapeutics
CTMX
<0,1%
−51,8%
B
BlossomHill Therapeutics
BLSM
<0,1%
A
Arvinas
ARVN
<0,1%
−34,5%
R
Relmada Therapeutics
RLMD
<0,1%
+7,7%
P
Puma Biotechnology
PBYI
<0,1%
+55,7%
C
C4 Therapeutics
CCCC
<0,1%
+11,3%
F
Faeth Therapeutics
FTH
<0,1%
−0,7%
E
Eikon Therapeutics
EIKN
<0,1%
A
Agenus
AGEN
<0,1%
+51,9%
A
Allogene Therapeutics
ALLO
<0,1%
−31,8%
I
Immuneering
IMRX
<0,1%
−44,0%
C
Cypherpunk Technologies
CYPH
<0,1%
−8,8%
Z
Zentalis Pharmaceuticals
ZNTL
<0,1%
+26,9%
S
Sutro Biopharma
STRO
<0,1%
+21,1%
A
ALX Oncology
ALXO
<0,1%
−18,8%
F
Fate Therapeutics
FATE
<0,1%
+23,1%
I
Inovio Pharmaceuticals
INO
<0,1%
−27,0%
P
PDS Biotechnology
PDSB
<0,1%
−9,5%
C
Perspective Therapeutics
CATX
<0,1%
−55,5%
C
Corbus Pharmaceuticals
CRBP
<0,1%
−69,7%
A
Acrivon Therapeutics
ACRV
<0,1%
−36,4%
A
ABVC BioPharma
ABVC
<0,1%
−69,6%
A
Actuate Therapeutics
ACTU
<0,1%
−95,5%
A
Allarity Therapeutics
ALLR
<0,1%
−24,9%
A
AIM ImmunoTech
AIM
<0,1%
−64,1%
B
BioAtla
BCAB
<0,1%
−95,0%
A
Ascentage Pharma Group International
AAPG
−55,6%
A
Adagene
ADAG
−3,4%
A
ADC Therapeutics
ADCT
−66,9%
A
Adlai Nortye
ANL
+559,0%
A
Autolus Therapeutics
AUTL
−14,0%
A
AstraZeneca
AZN
B
BioNTech
BNTX
−23,4%
E
Electra Therapeutics
ETRA
G
Genmab
GMAB
+68,6%
G
GSK
GSK
+8,6%
H
HUTCHMED
HCM
−2,5%
I
Iambic Therapeutics
IAM
I
Immunocore
IMCR
−15,2%
I
Immatics
IMTX
−40,1%
J
Jazz Pharmaceuticals
JAZZ
+76,7%
N
Nanobiotix
NBTX
+42,1%
N
Novartis
NVS
+23,7%
O
BeOne Medicines
ONC
+10,4%
R
Roche Holdings
RHHBY
+21,9%
T
Takeda Pharmaceutical
TAK
+54,2%
T
Telix Pharmaceuticals
TLX
−5,9%
U
UroGen Pharma
URGN
+4,1%
Z
Zai Lab
ZLAB
+12,4%

Notizie del tag

Whitehouse vende Amgen e alleggerisce la posizione in Microsoft
lun 9 nov
Moderna alza al 15%-25% la previsione di crescita delle vendite 2026
ven 6 nov
Pfizer alza le previsioni di vendite 2026 da 62 a 64 miliardi di dollari
ven 6 nov
Revolution Medicines registra 197,6 milioni di dollari nelle prime vendite di Rasonque
gio 5 nov

Tag vicini

Immunoterapia oncologica
Oncoematologia
Tumori femminili
Grandi case farmaceutiche